Test for carcinogenesis of cigarette tobacco smoke condensate using young strong A and C57 Bl mice. by Flaks, A.
145
TEST FOR CARCINOGENESIS OF CIGARETTE TOBACCO SMOKE
CONDENSATE USING YOUNG STRONG A AND C57 BL MICE
ANTONIA FLAKS
From, the Department of Experimental Pathology and Cancer Research,
School ofMedicine, Leeds
Received for publication November 9, 1965
THE work here was designed on the basis of a previous experiment (Flaks,
1965), in which it was shown that Strong A mice are highly susceptible to the
induction of adenoma of the lung, following the administration of 30 pg. of
9:,10-dimethyl-l.2-benzanthracene (DMBA) to young animals.
In the present experiment, the test substances, denicotinized whole cigarette
tobacco smoke condensate and its neutral fraction were tested.
The method for testing substances for carcinogenicity by subcutaneous in-
jection into new-born mice, has been reported by Pietra, Spencer and Shubik
(1959). Pietra, Rappaport and Shubik (1961), Stich (1960) and Roe, Rowson and
Salaman (1961) using DMBA. Kelly and O'Gara (1961) and O'Gara, Kelly and
AManitel (1962) reported favourable results with 1,2: 5,6-dibenzanthracene and
20-methl\lcholanthrene. Roe, Mitchley and Walters (1963) tested 1,2-benz-
anthracene, 2-naphthylamine, 2-naphthylhydroxylamine and ethyl methane
sulphonate and Grant and Roe (1963) investigated the interaction of phen-
anthrene with benzopyrene in carcinogenesis using the same technique.
Extensive work has been performed on the carcinogenic activity of tobacco
smoke condensates; the review by Wynder and Hoffmann (1964) is cited.
MATERIALS AND METHODS
The animals used were Strong A and C57B1 strains ofmice, bred in this labora-
tory by selective brother-sister mating.
The test substances used were whole denicotinized cigarette tobacco smoke
condeinsate and its neutral fraction. Both were prepared by the Tobacco Research
Council, using the smoking technique recommended by the Tobacco Manufac-
turers Standing Committee (Bentley and Burgan, 1961). The removal of nico-
tine was necessary, owing to its high toxicity.
Suspensions of condensates in 30/' aqueous gelatine were prepared by adding
acetone solutions of condensates to the gelatine at 56° C. The acetone was
removed by passing a nitrogen stream through the suspension.
Treated and solvent-control animals were placed in groups of sixty mice,
containing equal number ofmales and females. For each test substance and each
strain of mice, new-born (up to 12 hours old), seven- and fourteen-days-old groups
were used.
Test animals of all groups received one subcutaneous injection, in the inter-
scapular region, of 300 ,ag. of test substance in 15 ,lt. of 30o aqueous gelatine.
Solvent controls received 15 pl. of 3%0 aqueous gelatine only. Animals without
treatment were also included.ANTONIA FLAKS
The experiment was terminated after twelve months and all animals were
examined macroscopically and subsequently histologically.
RESULTS
Mortality was high during the first days after injection, and all mice which
died before the age of five weeks were replaced. After the initial losses the death
rate was very low.
Up to the 11th month no mice which died showed any neoplastic lesions;
therefore all animals which died up to this time are excluded from the final results.
No difference was found, in mean body weight, between test and control
groups. There was no difference in the effect of test substances between males
and females.
C57B1 mice showed no response to the test substances, therefore only the
results for Strong A mice are considered (Tables I and II).
No tumours were found at the site of injection or any other organ, except the
lungs. The number ofadenomata per lung was assessed by counting those visible
at post-mortem.
TABLE I.-Whole denicotinized cigarette tobacco smoke condensate
Survivors Averago
died or number
Age of killed Survivors oflung
mice at Number between with adenomata
injection ofmice 11th & 12th lung per
(days) injected month adenomata survivor
0 . 60 . 46 . 22 (47 8%) . 15
7 . 60 . 44 . *18 (40.9%) . 15
14 . 60 . 48 . 14 (29-2%) . 1-4
* One carcinoma ofthe lung.
TABLE II.-INTeutralfraction of cigarette tobacco smoke condensate
Survivors Average
died or number
Age of killed Survivors of lung
mice at Number between with adenomata
injection ofmice 11th & 12th lung per
(days) injected month adenomata survivor
0 . 60 . 48 . 13 (27%) . 1-4
7 . 60 46 . 12 (26-1%) . 1-2
14 . 60 . 49 . 10 (20.4%) . 1-3
Solvent control:
0 days 60 mice-no neoplastic lesions.
7 days-60 mice-one mouse with one adenoma of the lung.
14 days-60 mice-no neoplastic lesions.
Untreated control:
60 mice-two mice with mammary carcinoma.
DISCUSSION
As shown in Table I a high proportion of mice treated with whole cigarette
tobacco smoke condensate developed lung adenomata. New-born mice showed
the highest susceptibility, although one carcinoma of the lung did arise in the
seven-days-old group.
In Table II, where the test substance was the neutral fraction of cigarette
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smoke condensate, the highest tumour incidence is also shown to be in new-born
animals.
Comparing the results in Tables I and II, it would appear that the whole
cigarette smoke condensate yields a higher percentage of lung adenomata than
its neutral fraction which contains the hydrocarbons. This would confirm the
report of Wynder and Hoffmann (1959) that the neutral fraction alone does not
account for the carcinogenic activity of cigarette smoke condensate; some other
carcinogenic compounds or tumour promoting agents may be present.
The cigarette tobacco smoke condensates tested here gave positive results,
judging by the latent period, the number of animals bearing the tumours and the
number oftumours per lung. In a previous paper (Flaks, 1965) DMBA has shown
greater activity in all these respects, so it can be said that the carcinogenic activity
of the condensates appears to be weak.
SUMMARY
In groups of sixty, Strong A and C57B1 mice, when new-born, seven and
fourteen days old, were given one subcutaneous injection of 300 ,ug. of whole
denicotinized or neutral fraction of cigarette tobacco smoke condensate in 15 ,ul.
of 3%0 aqueous gelatine solution. Solvent-control received 15 ,lt. of 3% aqueous
gelatine solution and a further group received no treatment.
The experiment was terminated one year after injection. Animals were
examined macroscopically and microscopically.
C57B1 mice did not give any response to the test substances and therefore only
results obtained from Strong A mice are discussed.
The response to both condensates, in terms of pulmonary tumour incidence,
was weak but positive and the latent period was eleven months.
There was higher incidence of lung adenomata in groups treated with whole
condensate than in those treated with its neutral fraction. It appears, therefore,
that the carcinogenic activity of cigarette smoke condensate is not confined to its
neutral fraction but there may be other carcinogens or tumour promoting agents
in whole condensate.
I wish to acknowledge the interest and support received from Professor H. N.
Green and the pathologist, Dr. J. 0. Laws, for the histological reports.
These investigations were carried out under a grant from the Tobacco Research
Council.
REFERENCES
BENTLEY, H. R. AND BURGAN, J. R.-(1961) Res. Pap. Tab. Mfrs' stand. Comm. (2nd
edition), No. 4.
FLAKS, A.-(1965) Br. J. Cancer, 19, 547.
GRANT, G. AND ROE, F. J. C.-(1963) Br. J. Cancer, 17, 261.
KELLY, M. G. AND O'GARA, R. W.-(1961) J. natn. Cancer Inst., 26, 651.
O'GARA, R. W., KELLY, M. G. AND MANTEL, N.-(1962) Nature, Lond., 196, 1220.
PIETRA, G. RAPPAPORT, H. AND SHUBIK, P.-(1961) Cancer, N.Y., 14, 308.
PIETRA, G., SPENCER, K. AND SHUBIK, P.-(1959) Nature, Lond., 183, 1689.
ROE, F. J. C., MITCHLEY, B. C. V. AND WALTERS, M.-(1963) Br. J. Cancer, 17, 255.
ROE, F. J. C., RowsoN, K. E. K. AND SALAMAN, M. H.-(1961) Br. J. Cancer, 15, 515.
STICH, H. F.-(1960) J. natn. Cancer Inst., 25, 649.
WYNDER, E. L. AND HOFFMANN, D.-(1959) Cancer, N.Y., 12, 1079.-(1964) Adv. Cancer
Res., 8, 249.